Get startedLog in
    Picture of Sapporo Clinical Laboratory logo

    9776 — Sapporo Clinical Laboratory Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    Consumer DefensivesConservativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Sapporo Clinical Laboratory, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS
    JAS
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line8451,1761,502960598
    Depreciation
    Non-Cash Items1441246.4211-70.8
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital21.4-622-522-25914.8
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities1,2568381,5741,4301,078
    Capital Expenditures-2,984-3,153-948-826-448
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items70.74.5811741752.2
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-2,913-3,148-831-409-395
    Financing Cash Flow Items—-0.001220-0.001-32
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-51.61,944-113-348-370
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-1,709-367630673312